MD

Mondelez International, Inc.

MDLZConsumer DefensiveNASDAQ

Confectioners

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$38.54B
+5.8% YoY
Net Income
$2.45B
-46.8% YoY
EBITDA
$4.97B
-38.4% YoY
Free Cash Flow
$2.25B

Scan Results

Daily timeframe
DateIndicatorDetails
Aug 31 MACD Negative CrossoverHistogram -0.1726, negative momentum
Aug 29 MACD Negative CrossoverHistogram -0.1726, negative momentum
About Mondelez International, Inc.

Mondelez International, Inc., through its subsidiaries, manufactures, markets, and sells snack food and beverage products in Latin America, North America, Asia, the Middle East, Africa, and Europe. With a market capitalization of $78.21B, it sits in large-cap territory. The company provides biscuits and baked snacks, including cookies, crackers, salted snacks, snack bars, and cakes and pastries; chocolates; and gums and candies, as well as various cheese, grocery, and powdered beverage products.

Where MDLZ stands vs its 150-day and 200-day moving averages

As of the August 31, 2026 close, MDLZ finished 4.56% above its 150-day moving average ($59.64) and 7.00% above its 200-day moving average ($58.28). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is MDLZ overbought or oversold?

At the August 31, 2026 close, MDLZ's RSI(14) was 54.9, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$78.21B
P/E (TTM)22.53
Fwd P/E18.23
EPS$2.72
Beta0.40
52W Change-0.8%
Dividend Yield3.38%
ROE13.3%
Analysis

Mondelez International, Inc. carries $22.06B in total debt against $1.72B in cash reserves — debt is roughly 12.9x the cash position. Managing this leverage effectively will be important for long-term financial stability. The company generates $2.25B in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Return on equity stands at 13.3%, which is decent for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 4.1% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $31.50B (2022) to $38.54B (2025), reflecting a 22% increase over the period.

MDLZ's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. The debt-to-cash ratio suggests meaningful leverage on the balance sheet, a factor worth monitoring if credit conditions tighten. No single metric tells the full story. Reviewing MDLZ's risk profile alongside its fundamentals and technical indicators provides a more complete picture.

Links
More Consumer Defensive stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms